| Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 |
|---|---|---|---|---|---|---|---|---|
Sales | ||||||||
0 | 530 | - | - | - | - | - | - | - |
Sales | ||||||||
- | - | 540 | 621 | 61 | 0 | - | - | - |
Cost of goods sold | ||||||||
1 | 427 | 380 | 485 | 50 | 0 | - | - | - |
Co-development revenue | ||||||||
- | - | - | - | - | - | 93 | 0 | - |
Cost of co-development revenue | ||||||||
- | - | - | - | - | - | 88 | 0 | - |
Gross profit (loss) | ||||||||
-1 | 103 | 160 | 136 | 11 | 0 | 5 | 0 | - |
Operating expenses: | ||||||||
Research and development, net of grants | ||||||||
3,056 | 4,052 | 4,712 | 4,831 | 2,932 | 2,217 | 1,851 | 1,184 | 463 |
General and administrative | ||||||||
5,526 | 5,622 | 5,160 | 6,510 | 5,021 | 5,084 | 3,450 | 3,026 | 2,516 |
Total operating expenses | ||||||||
8,582 | 9,674 | 9,872 | 11,341 | 7,953 | 7,301 | 5,301 | 4,210 | 2,979 |
Loss from operations | ||||||||
-8,583 | -9,571 | -9,712 | -11,205 | -7,942 | -7,301 | -5,296 | -4,210 | -2,979 |
Other income: | ||||||||
Interest income | ||||||||
101 | 71 | 32 | 32 | 44 | 5 | 11 | 22 | 3 |
Interest expense | ||||||||
- | - | - | - | - | - | - | 1 | 0 |
Total other income (expense) | ||||||||
- | - | - | - | - | - | - | 21 | 3 |
Net loss | ||||||||
-8,479 | -9,500 | -9,680 | -11,173 | -7,898 | -7,296 | -5,285 | -4,189 | -2,976 |
Net loss | ||||||||
-8,482 | -9,500 | - | - | - | - | - | - | - |
Net loss attributed to noncontrolling interest | ||||||||
-3 | - | - | - | - | - | - | - | - |
Net loss per share - basic and fully diluted | ||||||||
0.32 | 0.42 | 0.63 | -0.86 | -0.63 | -0.77 | -0.60 | -0.55 | -0.67 |
Weighted average number of shares outstanding - basic and fully diluted | ||||||||
26,701 | 22,856 | 15,421 | 12,928 | 12,461 | 9,507 | 8,795 | 7,596 | 4,435 |